SCIENTIFIC BACKGROUND

ABCB7, ABHD12, ADGRG1, AFG3L2, AHI1, AMACR, ARL13B, ARSA, ATCAY, ATM, ATP1A3, ATP8A2, ATXN10, BTD, CA8, CAPN1, CC2D2A, CEP290, CEP41, CLCN2, CLN5, CLN6, COQ8A, CP, CPLANE1, CSPP1, CYP27A1, DARS2, DLAT, DNAJC19, DNMT1, FLVCR1, GALC, GBA, GBA2, GJB1, GOSR2, INPP5E, KIAA0586, KIF1C, KIF7, MARS2, MRE11, MTPAP, NPC1, NPC2, NPHP1, OFD1, OPA1, OPA3, PANK2, PDE10A, PDE6D, PEX10, PEX2, PLA2G6, PNPLA6, POC1B, POLG, POLR3A, RPGRIP1L, SACS, SIL1, SLC17A5, SPG7, TCTN1, TCTN2, TCTN3, TMEM138, TMEM216, TMEM231, TMEM237, TMEM67, TTC21B, VAMP1, VLDLR, WFS1, ZNF423

Scientific background

  • 3-methylglutaconic aciduria, type III (OPA3, AR)
  • 3-Methylglutaconic aciduria, type V (DNAJC19, AR)
  • Alpha-methylacyl-CoA racemase deficiency (AMACR, AR)
  • Anemia, sideroblastic, with ataxia (ABCB7, XL)
  • Ataxia telangiectasia (ATM, AR)
  • Ataxia telangiectasia-like disease (MRE11, AR)
  • Ataxia, autosomal recessive (PEX10, AR)
  • Ataxia, cerebellar, Cayman type (ATCAY, AR)
  • Behr syndrome (OPA1, AR)
  • Biotinidase deficiency (BTD, AR)
  • Boucher-Neuhauser syndrome (PNPLA6, AR)
  • CAPOS syndrome (ATP1A3, AD)
  • Cerebellar ataxia (CP, AR)
  • Cerebellar ataxia and mental retardation (CA8, AR)
  • Cerebellar ataxia and mental retardation 4 (?) (ATP8A2, AR)
  • Cerebellar ataxia with spasticity (GBA2, AR)
  • Cerebellar ataxia, deafness and narcolepsy, autosomal dominant (DNMT1, AD)
  • Cerebellar hypoplasia and mental retardation (VLDLR, AR)
  • Cerebrotendinous xanthomatosis (CYP27A1, AR)
  • Charcot-Marie-Tooth neuropathy, X-dominant, 1 (GJB1, XLD)
  • Epilepsy, progressive, myoclonic 6 (GOSR2, AR)
  • Gaucher disease type III (GBA, AR)
  • Infantile-onset limb and orofacial dyskinesia (PDE10A, AR)
  • Joubert syndrome phenotype (POC1B, AR)
  • Joubert syndrome type 1 (INPP5E, AR)
  • Joubert syndrome type 10 (OFD1, XLR)
  • Joubert syndrome type 11 (TTC21B, AR)
  • Joubert syndrome type 12 (KIF7, AR)
  • Joubert syndrome type 13 (TCTN1, AR)
  • Joubert syndrome type 14 (TMEM237, AR)
  • Joubert syndrome type 15 (CEP41, AR)
  • Joubert syndrome type 16 (TMEM138, AR)
  • Joubert syndrome type 17 (CPLANE1, AR)
  • Joubert syndrome type 18 (TCTN3, AR)
  • Joubert syndrome type 19 (ZNF423, AR)
  • Joubert syndrome type 2 (TMEM216, AR)
  • Joubert syndrome type 20 (TMEM231, AR)
  • Joubert syndrome type 21 (CSPP1, AR)
  • Joubert syndrome type 22 (PDE6D, AR)
  • Joubert syndrome type 23 (KIAA0586, AR)
  • Joubert syndrome type 3 (AHI1, AR)
  • Joubert syndrome type 4 (NPHP1, AR)
  • Joubert syndrome type 5 (CEP290, AR)
  • Joubert syndrome type 6 (TMEM67, AR)
  • Joubert syndrome type 7 (RPGRIP1L, AR)
  • Joubert syndrome type 8 (ARL13B, AR)
  • Joubert syndrome type 9 (CC2D2A, AR)
  • Joubert/Meckel syndrome phenotype (TCTN2, AR)
  • Joubert/nephronophthisis phenotype (ATXN10, AR)
  • Krabbe disease (GALC, AR)
  • Leukoencephalopathy with ataxia (CLCN2, AR)
  • Leukoencephalopathy with brainstem and spinal involvement and lactate elevation (DARS2, AR)
  • Marinesco-Sjogren syndrome (SIL1, AR)
  • Metachromatic leukodystrophy (ARSA, AR)
  • Mitochondrial recessive ataxia syndrome (POLG, AR)
  • Neurodegeneration with iron accumulation in the brain (PLA2G6, AR)
  • Neurodegeneration with iron accumulation in brain 1 (PANK2, AR)
  • Neuronal ceroid lipofuscinosis 5 (CLN5, AR)
  • Neuronal ceroid lipofuscinosis 6 (CLN6, AR)
  • Niemann-Pick disease, type C1 (NPC1, AR)
  • Niemann-Pick disease, type C2 (NPC2, AR)
  • Peroxisome biogenesis defect 5B (PEX2, AR)
  • Polymicrogyria, bilateral frontoparietal (ADGRG1, AR)
  • Polyneuropathy, ataxia, hearing loss, retinitis pigmentosa and cataract (ABHD12, AR)
  • Posterior column ataxia with retinitis pigmentosa (FLVCR1, AR)
  • Primary coenzyme Q10 deficiency type 4 (COQ8A, AR)
  • Pyruvate dehydrogenase E2 deficiency (DLAT, AR)
  • Salla disease (SLC17A5, AR)
  • Spastic ataxia (POLR3A, AR)
  • Spastic ataxia (SPG7, AR)
  • Spastic ataxia type 1 (VAMP1, AD)
  • Spastic ataxia type 2 (KIF1C, AR)
  • Spastic ataxia type 3 (MARS2, AR)
  • Spastic ataxia type 4 (MTPAP, AR)
  • Spastic ataxia type 5 (AFG3L2, AR)
  • Spastic ataxia, Charlevoix-Saguena type (SACS, AR)
  • Spastic paraplegia 76 (CAPN1, AR)
  • Wolfram syndrome (WFS1, AR)

 

Disorders are inherited in an autosomal dominant (AD), autosomal recessive (AR), X-linked (XL), or X-linked dominant (XLD) pattern.

 

For detailed information on ataxias and diagnostics, please visit our overview page ATAXIAS.

GENES

ABCB7, ABHD12, ADGRG1, AFG3L2, AHI1, AMACR, ARL13B, ARSA, ATCAY, ATM, ATP1A3, ATP8A2, ATXN10, BTD, CA8, CAPN1, CC2D2A, CEP290, CEP41, CLCN2, CLN5, CLN6, COQ8A, CP, CPLANE1, CSPP1, CYP27A1, DARS2, DLAT, DNAJC19, DNMT1, FLVCR1, GALC, GBA, GBA2, GJB1, GOSR2, INPP5E, KIAA0586, KIF1C, KIF7, MARS2, MRE11, MTPAP, NPC1, NPC2, NPHP1, OFD1, OPA1, OPA3, PANK2, PDE10A, PDE6D, PEX10, PEX2, PLA2G6, PNPLA6, POC1B, POLG, POLR3A, RPGRIP1L, SACS, SIL1, SLC17A5, SPG7, TCTN1, TCTN2, TCTN3, TMEM138, TMEM216, TMEM231, TMEM237, TMEM67, TTC21B, VAMP1, VLDLR, WFS1, ZNF423

ASSOCIATED TESTS

How to order

LATEST ARTICLES

Carrier screening is a genetic test designed to identify whether an individual carries a gene with changes (mutations) associated with inherited diso...

Read more

Trisomy 13, also known as Patau syndrome, is a genetic condition in which cells in the body have three copies of chromosome 13 instead of two. The co...

Read more

The human brain develops through a complex series of events, with genes carefully regulating the formation of neurons and glial cells. A recent study...

Read more

Rare diseases affect between 300 and 400 million people worldwide – more than cancer and AIDS combined [1, 2], but despite this, many people face a...

Read more

Rosalind Elsie Franklin was a brilliant and meticulous research scientist whose interdisciplinary work made fundamental contributions to various area...

Read more

February, designated as Cancer Awareness Month, marks a time to reflect on the remarkable progress made in cancer research and to inspire hope for th...

Read more

Introduction Cardiovascular disease (CVD) is a major health issue as it remains a leading cause of death worldwide [1]. CVD is responsible for mor...

Read more

Antimicrobial resistance (AMR) is one of the most pressing global health threats, and accurate identification and surveillance of multidrug-resistant...

Read more

Colorectal cancer remains a significant health concern globally. While genetic factors play a crucial role in its development, identifying the exact ...

Read more

A new meta-analysis links trans-kingdom gut microbiota (bacteria, eukaryotes, viruses, archaea) to immune checkpoint inhibitor (ICI) response in canc...

Read more